Food Allergies Tied to Irritable Bowel Syndrome
Title: Food Allergies Tied to Irritable Bowel SyndromeCategory: Health NewsCreated: 11/13/2015 12:00:00 AMLast Editorial Review: 11/13/2015 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - November 13, 2015 Category: Nutrition Source Type: news

Food Allergies Tied to Irritable Bowel Syndrome
Food allergies and genes that raise your odds of getting allergic diseases might play roles in some people's irritable bowel syndrome (IBS), two new studies suggest. WebMD has the details. (Source: WebMD Health)
Source: WebMD Health - November 12, 2015 Category: Consumer Health News Source Type: news

BIDMC researchers describe strategies to decrease immune responses in IBD
(Beth Israel Deaconess Medical Center) New research led by scientists at Beth Israel Deaconess Medical Center helps explain the role of an immunosuppressive pathway associated with irritable bowel disease, a condition that develops in genetically susceptible individuals when the body's immune system overreacts to intestinal tissue, luminal bacteria or both. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 10, 2015 Category: Cancer & Oncology Source Type: news

What Are Potential Treatments for Irritable Bowel Syndrome?
Discussion Abdominal pain is a common problem for children and a review can be found here.here. Functional gastrointestinal diseases are one of the most common problems not only in children but throughout the lifespan and a review can be found here. Irritable bowel syndrome (IBS) is the most common functional gastrointestinal diseases with 10 to 15% of children suffering from IBS. The cause is unknown but it is considered a brain-gut disorder. “It is postulated that the state of disregulation exists/occurs within the enteric and the central nervous systems in patients with IBS and this results in alteration in sensat...
Source: PediatricEducation.org - November 9, 2015 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Advances in Celiac Disease, IBS, IBD, and EoEAdvances in Celiac Disease, IBS, IBD, and EoE
A review of the new advances in the diagnosis and treatment of celiac disease, irritable bowel syndrome, inflammatory bowel disease, and eosinophilic esophagitis. Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 6, 2015 Category: Gastroenterology Tags: Gastroenterology Expert Column Source Type: news

Pfizer-Allergan deal a prelude to splitting company
(Reuters) — A Pfizer (NYSE:PFE) merger with Ireland-based Allergan (NYSE: AGN), in addition to providing tax benefits, would bolster the U.S. drugmaker’s growth prospects should it decide to sell or spin off its portfolio of products that have gone off patent. Many Wall Street analysts believe Pfizer will decide to split late next year, after compiling 3 years of financial data treating its “established products” division, which sells generic medicines, and its “innovative” patent-protected medicines unit, as if they were separate companies. Such a split would dramatically boos...
Source: Mass Device - November 6, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Pharmaceuticals Allergan Inc. Pfizer Inc. Source Type: news

Ironwood and Allergan begin Phase IIb trial of linaclotide colonic release in adults with IBS-C
Ironwood Pharmaceuticals and Allergan have started a Phase IIb trial, which will evaluate linaclotide colonic release in adults suffering from irritable bowel syndrome with constipation (IBS-C). (Source: Drug Development Technology)
Source: Drug Development Technology - November 3, 2015 Category: Pharmaceuticals Source Type: news

Stop Using My Disease to Stop Smoking
As part of its 2015 "Tips From Former Smokers" campaign, the CDC aired an anti-smoking ad that portrayed ostomies as punishment for a bad habit. This turned out to be part of a larger campaign that took advantage of diseases and complications tied to much more than smoking, twisting life-saving and preventative medical care into something akin to torture. Case in point, an ostomy isn't simply what you get for smoking your way to colorectal cancer. Ostomies also save thousands living with severe, incurable Irritable Bowel Disease (IBD). I'm a nonsmoker living with IBD, and I work in advertising. When I saw the CD...
Source: Healthy Living - The Huffington Post - October 27, 2015 Category: Consumer Health News Source Type: news

Evidence for IBS Diets Tough to SwallowEvidence for IBS Diets Tough to Swallow
Forget the dietary fads; gastrointestinal nutrition experts are applying scientific methods to tease out whether specific foods really do influence the course of irritable bowel syndrome (IBS). Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2015 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

How irritable bowel misery can be cured just by taking antibiotics
Nicola Hunter-Hostler, from Ipswich, Suffolk, has had a sensitive tummy for longer than she cares to remember. 'I've never been regular,' says Nicola, 43, a hairdresser. (Source: the Mail online | Health)
Source: the Mail online | Health - October 27, 2015 Category: Consumer Health News Source Type: news

Research finds new link between zonulin and two common inflammatory bowel conditions
(Spink Health) Researchers have discovered that people with non-coeliac gluten sensitivity (NCGS) and irritable bowel syndrome (IBS) have higher than normal blood levels of zonulin, suggesting an important role for the protein in the development of these conditions. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 27, 2015 Category: Biology Source Type: news

Doing a Food-Mood Journal: Cultivating Awareness
This article is not medical advice and is not intended as medical advice and is intended to provide only general, non-specific information related to health, and is not intended to cover all the issues related to the topic discussed. You should consult a licensed health practitioner before using any of the information from this article. References: 1. Friedman G. Diet and the irritable bowel syndrome. Gastroenterol Clin North Am. 1991 Jun;20(2):313-24. Department of Medicine, Mt. Sinai School of Medicine, New York, New York. 2. Happonen P, Voutilainen S, Salonen JT. Coffee drinking is dose-dependently related to the risk o...
Source: Healthy Living - The Huffington Post - October 23, 2015 Category: Consumer Health News Source Type: news

Swap Your White Pasta For One Of These 6 Healthier Varieties
Pasta night is under fire. Whether you're following a low-carb, gluten-free, low-glycemic index or low-calorie diet, the pasta you know and love is probably on your do-not-eat list. And without getting into the merits of every anti-white-pasta diet out there (which is basically every diet known to man), white pasta is a no-no for some pretty good reasons: During the milling process, white flour is stripped down to remove the grain’s bran and germ, and with them, fiber, protein, iron and B vitamins, explains Florida-based registered dietitian Jaime Mass. What remains on your plate is a quick-acting carb, not altogethe...
Source: Healthy Living - The Huffington Post - October 17, 2015 Category: Consumer Health News Source Type: news

Irritable Bowel Syndrome (IBS) Quiz: Test Your Medical IQ
Title: Irritable Bowel Syndrome (IBS) Quiz: Test Your Medical IQCategory: MedicineNet QuizCreated: 10/12/2015 4:03:00 PMLast Editorial Review: 10/13/2015 5:44:06 PM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 13, 2015 Category: Nutrition Source Type: news

Synthetic Biologics begins second Phase II SYN-010 trial to treat IBS-C
US-based Synthetic Biologics has started the second Phase II clinical trial of its proprietary SYN-010 to treat irritable bowel syndrome with constipation (IBS-C). (Source: Drug Development Technology)
Source: Drug Development Technology - October 9, 2015 Category: Pharmaceuticals Source Type: news

Research shows a cause of gastrointestinal symptoms in Type 1 diabetes
A molecular basis has been found for why 80 percent of patients with longstanding Type 1 diabetes have chronic gastrointestinal symptoms including gastroparesis (delayed emptying of food), irritable bowel syndrome, abdominal distension and fecal incontinence, significantly reducing their quality of life. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 1, 2015 Category: Science Source Type: news

Need, Greed, and GMOs: Genuflection in All the Wrong Directions
Images of scientists inserting eye-of-newt genes into escarole, or wool-of-bat genes into watercress stalk the nightmares of pure food proponents, and up to a point-- rightly so. Even if the intentions of those tinkering with foods are good- such as putting antifreeze genes from amphibians into oranges so they are not destroyed by an early frost- the law of unintended consequences pertains. There is ample reason, in principle, to be wary of Frankenfoods. There may be reason in epidemiology as well. We are substantially uncertain about why rates of gluten intolerance and celiac disease are rising; genetic modification of f...
Source: Healthy Living - The Huffington Post - September 22, 2015 Category: Consumer Health News Source Type: news

The One Thing I'm Realizing Two Years After My Eating Disorder
When I was in the deepest, darkest depths of my orthorexia, I had one fear that overwhelmed all of the others. Food. Not all food, but certainly most foods. While other young girls my age where enamored with boys, I was concerned with sandwiches. While other students in my college classes were going to happy hours, I was going to the gym and then straight home to bulk cook my specially prepared salt-less, fat-less, yummy-less meals. I was obsessed with not only eating clean and pure foods at all times of the day, but I was also obsessed with living an entire lifestyle that revolved around appearing healthy. Every semi-enjo...
Source: Healthy Living - The Huffington Post - September 10, 2015 Category: Consumer Health News Source Type: news

Doctor's Diary: Help for IBS sufferers may be on the way
New and emerging treatments for those with Irritable Bowel Syndrome will help diagnose their digestive problems (Source: The Telegraph : Health Advice)
Source: The Telegraph : Health Advice - September 7, 2015 Category: Consumer Health News Tags: Irritable Bowel Syndrome Mayo Clinic food allergies thyroid prostate tyramine pulsatile tinnitus coeliac disease IBS Doctor's Diary Dr Magnus Halland dustbin diagnosis James Le Fanu Source Type: news

Higher Colonic Bacterial Fermentation Linked to IBS SymptomsHigher Colonic Bacterial Fermentation Linked to IBS Symptoms
Altered colonic bacterial fermentation is associated with symptoms and colon transit time in individuals with irritable bowel syndrome (IBS), researchers report. Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 4, 2015 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Justine Gale had her appendix out but was still in agony because of Crohn's disease
Since she was a teenager, TV presenter Justine Gale had suffered stomach pain and diarrhoea which doctors put down to everything from irritable bowel syndrome to food poisoning. (Source: the Mail online | Health)
Source: the Mail online | Health - September 1, 2015 Category: Consumer Health News Source Type: news

'I cured my IBS': Three women reveal how they treated their irritable bowel syndrome
THREE women reveal the agonising toll irritable bowel syndrome took on their lives and how they found wonder treatments to beat it. (Source: Daily Express - Health)
Source: Daily Express - Health - August 16, 2015 Category: Consumer Health News Source Type: news

Irritable Bowel Syndrome: Little Evidence for FODMAP DietIrritable Bowel Syndrome: Little Evidence for FODMAP Diet
A review has found evidence to be lacking for a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) for irritable bowel syndrome. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 14, 2015 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Cutting Certain Carbs Might Not Ease Irritable Bowel Syndrome
Title: Cutting Certain Carbs Might Not Ease Irritable Bowel SyndromeCategory: Health NewsCreated: 8/7/2015 12:00:00 AMLast Editorial Review: 8/10/2015 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 10, 2015 Category: Nutrition Source Type: news

Cutting Certain Carbs Might Not Ease Irritable Bowel Syndrome
Research finds little evidence to support elimination diet's use (Source: WebMD Health)
Source: WebMD Health - August 7, 2015 Category: Consumer Health News Source Type: news

Cutting Certain Carbs Might Not Ease Irritable Bowel Syndrome
Research finds little evidence to support elimination diet's use Source: HealthDay Related MedlinePlus Pages: Carbohydrates, Diets, Irritable Bowel Syndrome (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 7, 2015 Category: Consumer Health News Source Type: news

Very little evidence for cutting out certain carbs to ease irritable bowel
There is very little evidence to recommend avoiding certain types of dietary carbohydrate, known as the FODMAP diet, to ease the symptoms of irritable bowel syndrome, or IBS for short, concludes a review of the available data. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 7, 2015 Category: Science Source Type: news

Woman with IBS goes from a size ten to a size zero to a size six
Jenna Birch, 23, from Ann Arbor, Michigan, was a size ten until the age of 21. The writer shrunk to a size zero (left) after suffering from irritable bowel syndrome. She is now a healthy size six (right). (Source: the Mail online | Health)
Source: the Mail online | Health - August 7, 2015 Category: Consumer Health News Source Type: news

IBS: The Truth About 9 Common Myths
WebMD debunks popular myths about irritable bowel syndrome (IBS). (Source: WebMD Health)
Source: WebMD Health - August 5, 2015 Category: Consumer Health News Source Type: news

UCLA scientists discover experimental therapy for chronic inflammatory bowel disease, colon cancer
UCLA scientists have discovered an experimental therapy capable of suppressing the development of ulcerative colitis, a disease that causes inflammation in the digestive tract. Ulcerative colitis patients have an increased risk of developing colon cancer, but doctors still are unsure why. The treatment uses a chemical to block an RNA molecule that’s involved in the transmission of genetic information and is typically found in high levels in people with ulcerative colitis. Dr. Dimitrios Iliopoulos, a member of UCLA’s Jonsson Comprehensive Cancer Center, and Dr. Christos Polytarchou, a UCLA assistant profess...
Source: UCLA Newsroom: Health Sciences - July 28, 2015 Category: Universities & Medical Training Source Type: news

What’s Useful for Managing IBS Symptoms?
NCCIH Director Dr. Josephine Briggs discusses the scientific evidence on complementary health approaches for irritable bowel syndrome (IBS). (Source: NCCAM Featured Content)
Source: NCCAM Featured Content - July 21, 2015 Category: Complementary Medicine Authors: NCCAM Source Type: news

Why Do People Do Yoga?
After my last weekend of yoga teacher training, a friend asked me over dinner, "Why do you do yoga? So you can learn to do what... headstands?" Why do people do yoga? More than 90 percent of people come to yoga for flexibility, stress relief, health, and physical fitness. But, for most people, their primary reason for doing yoga will change. Two-thirds of yoga students and 85 percent of yoga teachers have a change of heart regarding why they do yoga -- most often changing to spirituality or self-actualization, a sense of fulfilling their potential. Yoga offers self-reflection, the practice of kindness and self-c...
Source: Healthy Living - The Huffington Post - July 11, 2015 Category: Consumer Health News Source Type: news

Ironwood eyes China for IBS drug
Cambridge-based Ironwood Pharmaceuticals Inc. is reporting promising clinical trial data about its irritable bowel syndrome drug developed with AstraZeneca, news that has prompted the companies to look at Chinese regulatory approval. Data coming out of the trial indicates that the drug, known as linaclotide, significantly improved several areas of irritable bowel syndrome-constipation, including abdominal pain, bloating, and frequency of bowel movements. The most common adverse side effect was diarrhea. The… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 8, 2015 Category: American Health Authors: Jessica Bartlett Source Type: news

Pinaverium Effectively Treats IBS Symptoms in RCT Pinaverium Effectively Treats IBS Symptoms in RCT
Patients with irritable bowel syndrome who took pinaverium had significant improvement in abdominal pain and stool consistency compared with patients who took placebo in the double-blind trial. Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 8, 2015 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

In Case You Missed the Show: #MayoClinicRadio PODCAST July 4
LISTEN: MayoClinicRadio 07-04-15 PODCAST On this week's program, gastroenterologists Dr. Sunanda Kane and Dr. Yuri Saito discuss the differences between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), and explain how each is treated. Also on the program, Dr. Thomas Allison, director of the Mayo Clinic Sports Cardiology Program, talks about a simple treadmill [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 7, 2015 Category: Databases & Libraries Source Type: news

In Case You Missed the Show: #MayoClinicRadio PODCAST 7/4/2015
LISTEN: MayoClinicRadio 07-04-15 PODCAST On this week's program, gastroenterologists Dr. Sunanda Kane and Dr. Yuri Saito discuss the differences between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), and explain how each is treated. Also on the program, Dr. Thomas Allison, director of the Mayo Clinic Sports Cardiology Program, talks about a simple treadmill [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 7, 2015 Category: Databases & Libraries Source Type: news

IBD and IBS/Treadmill Test/Weight-Loss Maintenance: Mayo Clinic Radio
Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two very different chronic digestive system conditions that are sometimes confused with one another. On this week's program, gastroenterologists Dr. Sunanda Kane and Dr. Yuri Saito discuss the differences between IBD and IBS, and explain how each is treated. Also on the program, Dr. Thomas Allison, director  of [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 6, 2015 Category: Databases & Libraries Source Type: news

Mayo clinic radio
Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two very different chronic digestive system conditions that are sometimes confused with one another. On this week's program, gastroenterologists Dr. Sunanda Kane and Dr. Yuri Saito discuss the differences between IBD and IBS, and explain how each is treated. Also on the program, Dr. Thomas Allison, director  of [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 3, 2015 Category: Databases & Libraries Source Type: news

Pinaverium shows promising results for treatment of irritable bowel syndrome
Pinaverium offers quick and effective relief of irritable bowel syndrome (IBS) symptoms, according to clinical trial results. Pinaverium bromide (pinaverium), an antispasmodic, is used widely in many countries around the world, including European countries, Canada and Mexico. However, original clinical studies on pinaverium are scarce and there has been no convincing evidence for its effectiveness and safety. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 30, 2015 Category: Science Source Type: news

Viberzi (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D)
Viberzi (eluxadoline), an oral tablet developed by Actavis, is indicated for the treatment of adults suffering from irritable bowel syndrome with diarrhoea (IBS-D). (Source: Drug Development Technology)
Source: Drug Development Technology - June 10, 2015 Category: Pharmaceuticals Source Type: news

Hyperbaric hope for fibromyalgia sufferers
Women who suffer from fibromyalgia benefit from a treatment regimen in a hyperbaric oxygen chamber, according to researchers. Fibromyalgia is a chronic pain syndrome that can be accompanied by -- and perhaps related to -- other physical and mental conditions that include fatigue, cognitive impairment, irritable bowel syndrome and sleep disturbance. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 2, 2015 Category: Science Source Type: news

Monthly News Roundup - May 2015
Viberzi and Xifaxan FDA-Approved For Diarrhea-Predominant IBS Irritable bowel syndrome with diarrhea (IBS-D) may affect up to 15 million Americans, especially women, and treatment options are limited. In response, the U.S. Food and Drug... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2015 Category: Pharmaceuticals Source Type: news

Rifaximin for IBS: Where Do We Stand?Rifaximin for IBS: Where Do We Stand?
Dr David Johnson reviews the latest data on rifaximin treatment for diarrhea-predominant irritable bowel syndrome. Medscape Gastroenterology (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 29, 2015 Category: Drugs & Pharmacology Tags: Gastroenterology Commentary Source Type: news

FDA Approves Two New Treatments for Diarrhea-Predominant IBS (FREE)
By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS Eluxadoline (Viberzi) and rifaximin (Xifaxan) have both been approved to treat irritable bowel syndrome with diarrhea. The approvals … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 29, 2015 Category: Primary Care Source Type: news

New Meds OK’d for Hard-to-Treat IBS With Diarrhea
The FDA has approved two new prescription medications to treat irritable bowel syndrome with diarrhea, or IBS-D. It’s the latest step in a years-long struggle to find safe and effective treatments for the condition. (Source: WebMD Health)
Source: WebMD Health - May 28, 2015 Category: Consumer Health News Source Type: news

FDA Approves New Drugs for Irritable Bowel Syndrome
Both treat diarrhea that can strike some with the gastrointestinal disorderSource: HealthDay Related MedlinePlus Pages: Irritable Bowel Syndrome, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 28, 2015 Category: Consumer Health News Source Type: news

After Salix acquisition, Valeant receives FDA approval for IBS-D drug
Shares of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) traded up about 1.5 percent after markets closed Wednesday on news that the U.S. Food and Drug Administration approved the drug Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) in adult men and women. Quebec's Valeant acquired Xifaxan when it bought Raleigh’s Salix Pharmaceuticals for $11 billion, or $173 per share in cash, in April. Already, Xifaxan was Salix’s biggest seller, but the new indication could drive… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 28, 2015 Category: Biotechnology Authors: Jason deBruyn Source Type: news